Bio-Rad Laboratories (BIO) Cash from Investing Activities (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Cash from Investing Activities data on file, last reported at -$93.2 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 3313.79% year-over-year to -$93.2 million in Q1 2026; TTM through Mar 2026 was -$285.8 million, a 150.26% decrease from a year earlier, with the FY2025 full-year figure at -$189.7 million, down 18.41% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$93.2 million, down from -$34.2 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for BIO reached as high as $72.2 million in Q4 2023 and fell as low as -$916.1 million in Q1 2022.
• Historically, Cash from Investing Activities has averaged -$95.9 million across 5 years, with a median of -$43.1 million in 2024.
• Across the five-year window, Cash from Investing Activities soared 223.28% in 2023 and plunged 3313.79% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at -$58.6 million in 2022, then surged by 223.28% to $72.2 million in 2023, then plunged by 142.25% to -$30.5 million in 2024, then decreased by 12.13% to -$34.2 million in 2025, then plunged by 172.51% to -$93.2 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$93.2 million in Q1 2026, -$34.2 million in Q4 2025, and -$43.0 million in Q3 2025.